COVID's Impact on Medicare Spending

Published February 2026 · Updated July 2026 · 14 min read

The Unprecedented Dip

For the first time in the history of Medicare, total provider payments declined in 2020. This wasn't because healthcare got cheaper — it was because millions of Americans simply stopped going to the doctor. Elective surgeries were postponed. Routine screenings were skipped. Outpatient visits plummeted.

The data tells a stark story: from $89.5B in 2019 to $80.5B in 2020. Then a sharp recovery to $91.5B in 2021 as the healthcare system bounced back — and then some.

Winners and Losers

Not all specialties were affected equally. Surgical specialties saw the steepest declines — orthopedic surgeons, ophthalmologists, and cardiologists who depend on elective procedures took the biggest hit. Meanwhile, telehealth-compatible specialties like psychiatry and primary care adapted faster.

COVID testing itself became a massive new spending category. Codes like U0003, U0004, and U0005 (COVID-19 testing) appeared out of nowhere in 2020 and generated billions in Medicare payments by 2021-2022.

The Nursing Home Catastrophe

For Medicare beneficiaries in nursing homes and long-term care facilities, COVID was catastrophic. Over 200,000 nursing home residents died of COVID-19 in the first two years of the pandemic. Medicare spending on skilled nursing facilities dropped sharply in 2020 as admissions plummeted and discharge planning accelerated.

The pandemic exposed longstanding quality and staffing problems in nursing homes — facilities that receive significant Medicare funding. CMS responded with new minimum staffing requirements in 2024, but the nursing home industry argues these requirements are unfunded mandates that will force closures, particularly in rural areas.

The Telehealth Revolution

Perhaps the most lasting legacy of COVID on Medicare was the explosion of telehealth. Before the pandemic, telehealth accounted for less than 1% of Medicare visits. CMS emergency waivers removed geographic and originating-site restrictions virtually overnight, allowing any Medicare beneficiary to receive care via video or phone.

At the peak in April 2020, over 40% of Medicare primary care visits were delivered via telehealth. By 2024, the rate had settled to 5-8% — significantly higher than pre-pandemic but well below the peak. Congress has extended telehealth flexibilities through 2026, with debate ongoing about making them permanent.

The Deferred Care Crisis

The 2020 dip wasn't just a financial story — it was a health story. Millions of Medicare beneficiaries skipped cancer screenings, delayed cardiac evaluations, and postponed diabetic eye exams. Early data suggests this deferral led to later-stage cancer diagnoses in 2021-2022, more emergency cardiac events, and worse outcomes for chronic conditions.

Mammography screenings among Medicare beneficiaries dropped 87% in April 2020. Colonoscopies fell by 90%. While volumes recovered by late 2021, the missed window of early detection can't be recovered — and the downstream costs of late-stage diagnoses are far higher than the preventive screenings that were skipped.

The Bounce-Back

By 2021, Medicare spending not only recovered but exceeded pre-pandemic levels. This "revenge healthcare" phenomenon — patients catching up on deferred procedures — drove a surge that continued through 2023. The question now is whether spending has permanently shifted to a higher trajectory.

The Healthcare Worker Exodus

COVID didn't just disrupt Medicare spending — it disrupted the healthcare workforce. An estimated 18% of healthcare workers left the profession between 2020 and 2022 due to burnout, safety concerns, and pandemic fatigue. Nursing shortages became critical, with hospitals paying travel nurses 3-4x normal rates to fill gaps.

The workforce crisis continues to constrain capacity and drive up costs. Higher labor costs are baked into provider operations, contributing to the higher spending trajectory that has persisted post-pandemic. CMS has responded with workforce-related payment adjustments, but the fundamental supply-demand imbalance remains.

The PPE and Supply Chain Legacy

The pandemic exposed critical vulnerabilities in healthcare supply chains. Shortages of N95 masks, ventilators, and basic supplies like gloves and gowns forced providers to ration equipment and improvise. Medicare spending on personal protective equipment surged, with some providers billing premium prices for previously commodity items.

The experience drove policy changes: the Strategic National Stockpile was expanded, domestic manufacturing incentives were enacted, and CMS now requires healthcare facilities to maintain minimum supply reserves. These changes add ongoing costs but reduce vulnerability to future disruptions.

The Inflation Surge

COVID contributed to healthcare inflation that continues to affect Medicare. Labor costs surged as facilities competed for scarce workers. Supply costs increased due to supply chain disruptions. Construction costs for new facilities and renovations rose with broader inflation. All of these factors are now embedded in higher Medicare payment rates — the COVID-era cost increases didn't reverse when the pandemic ended. They became the new baseline.

CMS's Medicare Economic Index (MEI), which measures healthcare input costs, rose at its fastest rate in decades during 2021-2023. While the index has moderated in 2024-2026, cumulative inflation means Medicare is paying significantly more per service than it was pre-pandemic — a structural shift that contributes to the program's long-term fiscal challenges.

Was COVID a Turning Point?

In retrospect, COVID was both a disruption and an accelerant. It disrupted the steady upward trajectory of Medicare spending with an unprecedented dip. But it accelerated trends that were already underway: telehealth adoption, healthcare consolidation, the shift to Medicare Advantage, and the growing importance of data-driven healthcare delivery.

The question for policymakers is whether the post-COVID Medicare system is better or worse than what came before. The answer depends on where you look: better access through telehealth, worse workforce stability, higher costs, and a permanent reminder that the healthcare system's resilience cannot be taken for granted.

Our data captures every dimension of this story — from the 2020 spending cliff to the 2021 recovery surge to the new normal of 2023-2024. Explore the full dataset on our 10-Year Spending Explosion page, or dive into specific specialties and procedures to see exactly how COVID reshaped Medicare spending patterns.

The pandemic chapter may be closing, but its effects on Medicare — financial, structural, and human — will be felt for decades to come. The data tells that story, year by year, specialty by specialty, provider by provider.

The COVID Testing Gold Rush

COVID testing created one of the most rapid buildups of Medicare spending in program history. Laboratories — both established and newly created — raced to offer PCR testing, with Medicare paying $36-$100 per test. Some labs processed millions of tests, generating enormous revenue in a matter of months.

This rapid scaling also created fraud opportunities. The DOJ has prosecuted dozens of COVID testing fraud schemes, where labs billed Medicare for tests never performed or added unnecessary add-on tests to every COVID sample. Our COVID Test Gold Rush investigation covers these schemes in detail.

The Mental Health Surge

One of the most significant post-COVID trends in Medicare is the surge in mental health services. Psychiatry and psychology Medicare billing increased 35% from 2019 to 2023, driven by both increased need (pandemic-related anxiety, depression, and grief) and improved access through telehealth. Medicare telehealth policy now allows mental health visits from the patient's home — a dramatic expansion from the pre-pandemic requirement that patients be at a designated facility.

For Medicare beneficiaries aged 65+, who historically underutilized mental health services due to stigma and access barriers, the normalization of virtual mental health care may be COVID's most positive legacy.

Long-Term Structural Changes

COVID didn't just temporarily disrupt Medicare — it accelerated several long-term structural changes:

• Telehealth normalization — Video visits are now a permanent part of Medicare delivery
• Hospital-at-home — CMS expanded acute care at home programs that may outlast the pandemic
• Staffing crisis — Healthcare worker burnout and departures have constrained capacity, contributing to higher labor costs
• Supply chain awareness — Shortages of PPE and medications led to new domestic manufacturing incentives
• Infection control investment — Healthcare facilities invested heavily in air filtration, UV disinfection, and physical redesign
• Data infrastructure — COVID exposed gaps in real-time health data reporting, spurring investments in electronic reporting systems

Spending Trends 2014-2024